Chandra Bhagat Pharma (BOM:542934) ROCE %: 28.16% (As of Mar. 2026)


BOM:542934 Chandra Bhagat Pharma Ltd BOM:542934
73 GF Score
Price ₹42.70
GF Value ₹70.21
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Chandra Bhagat Pharma ROCE %?

Chandra Bhagat Pharma BOM:542934 -4.69% 73 ROCE % is 28.16% as of Mar. 2026. GuruFocus rates BOM:542934 with a GF Score™ of 73/100 and a GF Value™ of ₹70.21 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chandra Bhagat Pharma's annualized ROCE % for the quarter that ended in Mar. 2026 was 28.16%.

Chandra Bhagat Pharma  (BOM:542934) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chandra Bhagat Pharma ROCE % Related Terms

Chandra Bhagat Pharma ROCE % Historical Data

* Premium members only.

The historical data trend for Chandra Bhagat Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandra Bhagat Pharma ROCE % Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.13 9.81 11.03 9.88 17.96

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.11 9.55 10.56 8.79 28.16
BOM:542934
73GF Score
Chandra Bhagat Pharma Ltd BOM:542934
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandra Bhagat Pharma ROCE % Calculation

Chandra Bhagat Pharma's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=61.08/( ( (1015.304 - 692.489) + (942.058 - 584.823) )/ 2 )
=61.08/( (322.815+357.235)/ 2 )
=61.08/340.025
=17.96 %

Chandra Bhagat Pharma's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=94.266/( ( (882.01 - 569.824) + (942.058 - 584.823) )/ 2 )
=94.266/( ( 312.186 + 357.235 )/ 2 )
=94.266/334.7105
=28.16 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 28.16% mean?
Chandra Bhagat Pharma (BOM:542934) has a ROCE % of 28.16% as of Mar. 2026.
Is Chandra Bhagat Pharma's ROCE % too high?
Chandra Bhagat Pharma's current ROCE % is 28.16%. The Medical Distribution industry median ROCE % is 8.92. Chandra Bhagat Pharma's value of 28.16% is 215.7% above this industry median. Overall, Chandra Bhagat Pharma has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's ROCE % compare to MCK and CAH?
Chandra Bhagat Pharma's ROCE % of 28.16% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 8.92. Chandra Bhagat Pharma's value of 28.16% is 215.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 8.92, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chandra Bhagat Pharma's current ROCE % of 28.16% is 215.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 8.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandra Bhagat Pharma's current ROCE % is 28.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.21, compared to a current price of ₹42.70 — trading 39.2% below its estimated fair value. The current ROCE % is 28.16% and 215.7% above the Medical Distribution industry median of 8.92. Chandra Bhagat Pharma's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current ROCE % is 28.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?

Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued. The current stock price of ₹42.70 is trading 39.2% below its estimated GF Value™ of ₹70.21. GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.

Key valuation signals for BOM:542934:

  • ROCE %: 28.16%
  • GF Value™: ₹70.21 vs. price of ₹42.70 (39.2% below fair value)
  • GF Score™: 73/100 with 4 warning signs
  • Industry Position: 215.7% above the Medical Distribution median

No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chandra Bhagat Pharma Business Description

Address Doctor Ambedkar Road, 323-F, Flat 1,2, Bhagat Bhuvan, Matunga East, Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
73GF Score

Get the complete analysis for BOM:542934

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹42.70
Price
₹70.21
GF Value